welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
Abstracts & Posters
The evaluation of bone age in patients with Duchenne muscular dystrophy on long-term glucocorticoid treatment
source: Neuromuscular Disorders
year: 2015
authors: E. Annexstad, J.Westvik, A. Myhre, J. Bollerslev, I. Holm, M.Rasmussen
summary/abstract:Long-term treatment with glucocorticoids (GCs) has a well-established effect on ambulation, prevention of scoliosis and preserved respiratory function in patients with Duchenne muscular dystrophy (DMD). However, as a new generation of GC treated DMD boys grow up to become young adults, long-term side effects of this treatment need to be addressed. A nationwide longitudinal study of paediatric DMD patients in Norway was set up to assess genotype/phenotype correlations; growth; puberty; bone health and quality of life.
organization: Centre for Congenital Neuromuscular Disorders, Norway; Oslo University Hospital, NorwayDOI: 10.1016/j.nmd.2015.06.050
read more
rareRelated
-
Corticosteroids for Duchenne Muscular DystrophyNeurologists from the American Academy o...
-
Learning Problems and Behavior in Duchennehttps://www.youtube.com/watch?v=rkbV8qsi...
-
Has outcome changed for adults with Duchenne muscular dystrophy?We investigated the cause of death, the ...
-
A Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids, in Subjects With Non-ambulat...To evaluate the efficacy and safety of p...
-
Bone health and osteoporosis management of the patient with Duchenne muscular dystrophyDuchenne muscular dystrophy is associate...
-
Bone health in boys with Duchenne Muscular Dystrophy on long-term daily deflazacort therapyQuality of life in Duchenne Muscular Dys...
-
Corticosteroid treatment and growth patterns in ambulatory males with Duchenne Muscular DystrophyObjectives: To evaluate growth patterns...
